Healthcare -
Biotechnology - NASDAQ - US
$ 92.02
-4.71 %
$ 5.88 B
Market Cap
-86.0
P/E
BPMC - COST OF REVENUE
Cost of Revenue BPMC - Blueprint Medicines Corporation
20.2 M
LAST VALUE
6.39%
2 YEAR CAGR
0.00%
5 YEAR CAGR
-4.47%
10 YEAR CAGR